NUJUPA

Serial Number 88637566
606

Registration Progress

Application Filed
Oct 1, 2019
Under Examination
Mar 17, 2020
Approved for Publication
Jan 21, 2020
Published for Opposition
Jan 21, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NUJUPA
Previous Owner: AbbVie Biotechnology Ltd
Classes: 005

Trademark Image

NUJUPA

Basic Information

Serial Number
88637566
Filing Date
October 1, 2019
Published for Opposition
January 21, 2020
Abandonment Date
April 17, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 17, 2023
Classes
005

Rights Holder

AbbVie Biotechnology Ltd

03
Address
Thistle House, 4 Burnaby Street
Hamilton, Pembroke HM11
BM

Ownership History

AbbVie Biotechnology Ltd

Original Applicant
03
Hamilton BM

AbbVie Biotechnology Ltd

Owner at Publication
03
Hamilton, Pembroke BM

Legal Representation

Attorney
Cheryl A. Withycombe

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

31 events
Date Code Type Description Documents
Apr 17, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 17, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 8, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 30, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 8, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 30, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 11, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 11, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 21, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 17, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 17, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 17, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 8, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 8, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 18, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 16, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 16, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 16, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 17, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 21, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 21, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 1, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 16, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 13, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 4, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 4, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification

International Classes
005